L&G Healthcare Breakthrough UCITS ETF
IE00BK5BC677
L&G Healthcare Breakthrough UCITS ETF/ IE00BK5BC677 /
NAV2024-04-18 |
Chg.-0.0497 |
Type of yield |
Investment Focus |
Investment company |
10.7098USD |
-0.46% |
reinvestment |
Equity
Worldwide
|
LGIM Managers (EU) ▶ |
Investment strategy
The Fund is a passively managed exchange traded Fund that is a passively managed exchange traded Fund ("ETF") that aims to track the performance of the ROBO Global® Healthcare Technology and Innovation Index TR (the "Index"), subject to the deduction of the ongoing charges and other costs associated with operating the Fund.The Fund has a sustainable investment objective as it invests in companies which (i) contribute to social objectives, (ii) do not significantly harm any environmental or social objectives, and (iii) follow good governance practices.
Shares in this Share Class (the "Shares") are denominated in USD and can be bought and sold on stock exchanges by ordinary investors using an intermediary (e.g. a stockbroker). In normal circumstances, only Authorised Participants may buy and sell Shares directly with the Company. Authorised Participants may redeem their Shares on demand in accordance with the "Dealing Timetable" published on http://www.lgim.com.The Index is comprised of companies which are publically traded on various stock exchanges around the world that generate a proportion of their revenues from the healthcare technology industry. The industry is deemed to be comprised of the following nine subsectors: diagnostic, lab process automation, genomics, regenerative medicine, precision medicine, telehealth, data analytics, robotics and medical instruments. A company is only eligible for inclusion in the Index if it is of a sufficient size (determined by reference to the total market value of its shares) and it is sufficiently "liquid" (a measure of how actively its shares are traded on a daily basis).
Investment goal
The Fund is a passively managed exchange traded Fund that is a passively managed exchange traded Fund ("ETF") that aims to track the performance of the ROBO Global® Healthcare Technology and Innovation Index TR (the "Index"), subject to the deduction of the ongoing charges and other costs associated with operating the Fund.The Fund has a sustainable investment objective as it invests in companies which (i) contribute to social objectives, (ii) do not significantly harm any environmental or social objectives, and (iii) follow good governance practices.
Master data
Type of yield: |
reinvestment |
Funds Category: |
Equity |
Region: |
Worldwide |
Branch: |
ETF Stocks |
Benchmark: |
ROBO Global® Healthcare Technology and Innovation Index |
Business year start: |
07-01 |
Last Distribution: |
- |
Depository bank: |
The Bank of New York Mellon SA/NV |
Fund domicile: |
Ireland |
Distribution permission: |
Austria, Germany, Switzerland |
Fund manager: |
- |
Fund volume: |
67.46 mill.
USD
|
Launch date: |
2019-06-17 |
Investment focus: |
- |
Conditions
Issue surcharge: |
0.00% |
Max. Administration Fee: |
0.49% |
Minimum investment: |
1.00 USD |
Deposit fees: |
- |
Redemption charge: |
0.00% |
Key Investor Information: |
Download (Print version) |
Investment company
Funds company: |
LGIM Managers (EU) |
Address: |
2 Dublin Landings, 1-W-131, Dublin |
Country: |
Ireland |
Internet: |
www.lgim.com/ie/
|
Assets
Stocks |
|
99.85% |
Cash |
|
0.13% |
Others |
|
0.02% |
Countries
United States of America |
|
79.51% |
Switzerland |
|
5.99% |
Netherlands |
|
3.37% |
Italy |
|
1.67% |
Germany |
|
1.66% |
Luxembourg |
|
1.59% |
Jersey |
|
1.43% |
Canada |
|
1.31% |
China |
|
1.25% |
United Kingdom |
|
1.14% |
Japan |
|
0.93% |
Cash |
|
0.13% |
Others |
|
0.02% |
Branches
Healthcare |
|
95.71% |
IT/Telecommunication |
|
2.89% |
Consumer goods |
|
1.25% |
Cash |
|
0.13% |
Others |
|
0.02% |